MedPath
NMPA Approval

Lamivudine Oral Solution

国药准字HJ20140181

May 12, 2021

H20140181

Drug Information

拉米夫定口服溶液

益平维

口服溶液剂

240ml:2.4g

化学药品

May 12, 2021

May 11, 2026

Company Information

Applicant Company

ViiV Healthcare BV

Huis ter Heideweg 62,3705 LZ Zeist,The Netherlands.

Manufacturing Company

ViiV Healthcare BV

7333 Mississauga Road North, Mississauga, Ontario, Canada, L5N, 6L4

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

拉米夫定口服溶液 - NMPA 批准文号 | MedPath